A detailed history of Cedar Mountain Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 1,000 shares of EYPT stock, worth $7,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$7,330
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$8.89 - $14.92 $88,900 - $149,200
-10,000 Reduced 90.91%
1,000 $10,000
Q4 2020

Jan 28, 2021

BUY
$3.7 - $6.58 $40,700 - $72,380
11,000 New
11,000 $72,000

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $250M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.